Search

Your search keyword '"Grützmann, Robert"' showing total 1,231 results

Search Constraints

Start Over You searched for: Author "Grützmann, Robert" Remove constraint Author: "Grützmann, Robert"
1,231 results on '"Grützmann, Robert"'

Search Results

151. A conditional piggyBac transposition system for genetic screening in mice identifies oncogenic networks in pancreatic cancer

152. Neoadjuvant Therapy for Resectable Pancreatic Cancer: A New Standard of Care. Pooled Data from Three Randomized Controlled Trials

154. CRISPR-Cas9 Screen Identifies DYRK1A as a Target for Radiotherapy Sensitization in Pancreatic Cancer

155. Influence of Gender on Radiosensitivity during Radiochemotherapy of Advanced Rectal Cancer

156. Surgical and oncological outcome after extended lymph node dissection for carcinoma of the stomach and the esophagogastric junction; a retrospective analysis from experienced single center.

157. The outcome of patients with inflammatory bowel disease–associated colorectal cancer is not worse than that of patients with sporadic colorectal cancer–a matched-pair analysis of survival

160. Correction to: Outcomes After Distal Pancreatectomy with Celiac Axis Resection for Pancreatic Cancer: A Pan-European Retrospective Cohort Study

161. Whole genomes redefine the mutational landscape of pancreatic cancer

163. Identification of Genes Associated with Liver Metastasis in Pancreatic Cancer Reveals PCSK6 as a Crucial Mediator.

165. A Possible Distinct Molecular Subtype (Quintuple-Wildtype) of Metastatic Colorectal Cancer in First-Line Anti-EGFR Therapy with Cetuximab Plus FOLFIRI – Palliative Precision Therapy and a Multidisciplinary Treatment Approach: Interim Analysis of the IVOPAK II Trial with Early Results

168. Quality of life of GIST patients with and without current tyrosine kinase inhibitor treatment: Cross‐sectional results of a German multicentre observational study (PROSa)

174. PAK1 mediates pancreatic cancer cell migration and resistance to MET inhibition

177. Targeting DNA damage response and replication stress in pancreatic cancer

178. Neoadjuvant Therapy for Resectable Pancreatic Cancer

180. Plasma Metabolome Profiling Identifies Metabolic Subtypes of Pancreatic Ductal Adenocarcinoma

181. Lipomatous Solitary Fibrous Tumors Harbor Rare NAB2-STAT6 Fusion Variants and Show Up-Regulation of the Gene PPARG, Encoding for a Regulator of Adipocyte Differentiation

183. Deep Learning Improves Pancreatic Cancer Diagnosis Using RNA-Based Variants

184. The health-related quality of life of sarcoma patients and survivors in germany—cross-sectional results of a nationwide observational study (PROSa)

185. Quality of life of GIST patients with and without current tyrosine kinase inhibitor treatment: cross-sectional results of a German multicentre observational study (PROSa)

186. Significance of Examined Lymph Node Number in Accurate Staging and Long-term Survival in Resected Stage I-II Pancreatic Cancer-More is Better?: A Large International Population-based Cohort Study

187. Contributors

190. Precision Oncology in Surgery

192. Gene Expression in Solitary Fibrous Tumors (SFTs) Correlates with Anatomic Localization and NAB2-STAT6 Gene Fusion Variants

193. Proposal of a Standardized Questionnaire to Structure Clinical Peer Reviews of Mortality and Failure of Rescue in Pancreatic Surgery

194. Neoadjuvant Chemoradiation Combined with Regional Hyperthermia in Locally Advanced or Recurrent Rectal Cancer

195. Neoadjuvant concurrent chemoradiotherapy with and without hyperthermia in retroperitoneal and intra-abdominal sarcomas: Feasibility, efficacy, toxicity and long-term outcome

196. Identification and validation of a multivariable prediction model based on blood plasma and serum metabolomics for the distinction of chronic pancreatitis subjects from non-pancreas disease control subjects

Catalog

Books, media, physical & digital resources